Literature DB >> 18319053

Influenza: preparedness for an inevitable "Emergency" for oncology and BMT units.

John R Wingard1.   

Abstract

Influenza is a seasonal and pandemic threat to the general population. The effects can be devastating for cancer patients and those who have undergone blood and marrow transplantation (BMT). However, this impact can be minimized. Emergency preparedness is the key to mitigating the impact on the oncology and BMT services. Having a plan that provides a framework of preparedness and outlines steps to take in the event of a community outbreak is crucial. A vigorous immunization campaign for patients, household contacts, and health care staff early in the season is the single most important action. In the midst of an outbreak, the oncology and BMT teams should act to quickly identify patients with suspected infections, move infected patients and staff away from noninfected patients to prevent contact, and decide which patients require prevention or treatment with antiviral agents. Ongoing engagement by the entire team to evaluate the effectiveness of its actions and modify its plan as necessary will ensure success.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18319053     DOI: 10.6004/jnccn.2008.0018

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  6 in total

1.  The preventive health behaviors of long-term survivors of cancer and hematopoietic stem cell transplantation compared with matched controls.

Authors:  Michelle M Bishop; Stephanie J Lee; Jennifer L Beaumont; Michael A Andrykowski; J Douglas Rizzo; Kathleen A Sobocinski; John R Wingard
Journal:  Biol Blood Marrow Transplant       Date:  2009-09-23       Impact factor: 5.742

Review 2.  Protecting pediatric oncology patients from influenza.

Authors:  Leslie S Kersun; Anne F Reilly; Susan E Coffin; Kathleen E Sullivan
Journal:  Oncologist       Date:  2013-01-31

3.  Influenza Among Breast Cancer Survivors in South Korea: A Nationwide Population-Based Study.

Authors:  Jaesung Heo; Mison Chun; Young-Taek Oh; O Kyu Noh; Logyoung Kim
Journal:  In Vivo       Date:  2017 Sep-Oct       Impact factor: 2.155

4.  Influenza vaccination and associated factors among Korean cancer survivors : a cross-sectional analysis of the Fourth & Fifth Korea National Health and Nutrition Examination Surveys.

Authors:  Kyung-Hyun Choi; Sang Min Park; Kiheon Lee; Ju Hyun Lee; Joo-Sung Park
Journal:  J Korean Med Sci       Date:  2014-07-30       Impact factor: 2.153

5.  Influenza A/pandemic 2009/H1N1 in the setting of allogeneic hematopoietic cell transplantation: a potentially catastrophic problem in a vulnerable population.

Authors:  Mohamed A Kharfan-Dabaja; Ana Velez; Karla Richards; John N Greene; Teresa Field; Ramon Sandin
Journal:  Int J Hematol       Date:  2009-12-16       Impact factor: 2.490

6.  COVID-19 and hematopoietic stem cell transplantation and immune effector cell therapy: a US cancer center experience.

Authors:  Katie Maurer; Anna Saucier; Haesook T Kim; Utkarsh Acharya; Clifton C Mo; Julie Porter; Cindy Albert; Corey Cutler; Joseph H Antin; John Koreth; Mahasweta Gooptu; Rizwan Romee; Catherine J Wu; Robert J Soiffer; Sarah Nikiforow; Caron Jacobson; Vincent T Ho
Journal:  Blood Adv       Date:  2021-02-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.